Feed HUM
HU

Humana HUM NYSE · Healthcare · United States

$380.10 -1.47% -$5.69

Summary

41 / 100 · Bulios Score

What speaks for it

  • Analysts expect revenue to grow by 26% this fiscal year.
  • Revenue grew by 12% a year over the last 3 years.

What to watch

  • Earnings per share fell by 24% a year over the last 3 years.
  • Out of every 100 USD of revenue, only 0.8 USD is left as net profit.
  • You pay 37.2 USD for 1 USD of yearly profit, a lot for its sector.
  • It earns only 4.4 USD a year on every 100 USD of invested capital.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Fairly priced
Bulios Fair Price
Fair Value Price today $380.1

By our assumptions the price matches the value of the business: the two differ by less than 10 %.

P/E today 37.2 58% higher
5-year average P/E 23.6
P/E today 37.2
Medical - Healthcare Plans industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 37.2 USD for 1 USD of yearly profit. Over the last five years it was 23.6 USD on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 11% a year over 5 years. Over the last 3 years it grew by 12% a year. For the next fiscal year analysts expect revenue to grow by 26%. Earnings per share fell by 24% a year over the last 3 years.

Growth in detail

Does it make money?

Poorly

Where 100 USD of revenue goes

Net profit, industry median (Medical - Healthcare Plans) 2.6 USD

Out of every 100 USD of revenue, 0.8 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

Repaying all its debt would take 16.7 years of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

Small, safe
Yield
0.92%
Paid out of profit
34%

You receive $3.54 per share a year. The company covers the payout with ease.

Dividends in detail

What do analysts expect?

Neutral

Today's price within the analysts' price targets

The average target of $473.74 is 25% above today's price. 48% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

By region

The company reports no revenue by region.

Insurance Segment brings in 85% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy